PTEN/MMAC1 in malignant melanoma and its importance for tumor progression

Citation
M. Poetsch et al., PTEN/MMAC1 in malignant melanoma and its importance for tumor progression, CANC GENET, 125(1), 2001, pp. 21-26
Citations number
28
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER GENETICS AND CYTOGENETICS
ISSN journal
01654608 → ACNP
Volume
125
Issue
1
Year of publication
2001
Pages
21 - 26
Database
ISI
SICI code
0165-4608(200102)125:1<21:PIMMAI>2.0.ZU;2-Z
Abstract
A novel tumor suppressor gene, PTEN/MMAC1, on 10q23, displayed a number of mutations in solid tumors as gliomas and breast cancer. Aberrations of the long arm of chromosome 10 have been frequently detected in tumor progressio n of malignant melanoma of the skin by a variety of methods including cytog enetic analysis, fluorescence in situ hybridization and loss of heterozygos ity analysis. Compared to previous studies, which propose an involvement of PTEN/MMAC1 in malignant melanoma mostly on the basis of data derived from cell lines and metastases, we analyzed a broader spectrum of exclusively pa tient derived tumor tissue by PCR and direct sequencing analysis of PTEN/ M MAC1. Here, we present data of 25 primary melanomas (8 superficial spreadin g melanomas, 17 nodular melanomas) and 25 metastases of 41 patients. Neithe r loss of the complete gene nor a whole exon nor any nonsense mutations cou ld be demonstrated. However, we detected several polymorphisms and some mut ations in the introns, and in two metastatic tumors mutations with an amino acid change. Our results obtained from tissue samples underline that mutat ions of PTEN/MMAC1 are not an essential event in the onset of malignant mel anoma of the skin, but could have an impact on tumor progression. (C) 2001 Elsevier Science Inc. All rights reserved.